Mortality, incidence, and microbiological documentation of ventilated acquired pneumonia (VAP) in critically ill patients with COVID-19 or influenza.

Guillaume LaurichesseCarole SchwebelNiccolò BuettiMathilde NeuvilleShidasp SiamiYves CohenVirginie LaurentBruno MourvillierJean ReignierDany Goldgran-ToledanoStéphane RucklyEtienne de MontmollinBertrand SouweineJean-François TimsitClaire Dupuisnull null

Published in: Annals of intensive care (2023)

The incidence of VAP was higher in patients ventilated for at least 48 h for COVID-19 than for influenza. In both groups, Gram-negative bacilli were the most frequently detected microorganisms. In patients ventilated for either COVID-19 or influenza VAP and COVID-19 were associated with a higher risk of mortality.

Keyphrases

coronavirus disease
gram negative
end stage renal disease
sars cov
intensive care unit
risk factors
ejection fraction
chronic kidney disease
newly diagnosed
acute respiratory distress syndrome
peritoneal dialysis
prognostic factors
type diabetes
respiratory syndrome coronavirus